CS235580B1 - Vaccination and modification alloy - Google Patents

Vaccination and modification alloy Download PDF

Info

Publication number
CS235580B1
CS235580B1 CS836478A CS647883A CS235580B1 CS 235580 B1 CS235580 B1 CS 235580B1 CS 836478 A CS836478 A CS 836478A CS 647883 A CS647883 A CS 647883A CS 235580 B1 CS235580 B1 CS 235580B1
Authority
CS
Czechoslovakia
Prior art keywords
modification
iron
alloy
vaccination
silicon
Prior art date
Application number
CS836478A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS647883A1 (en
Inventor
Jan Harmaniak
Ervin Kovacik
Pavol Konecny
Vitezslav Latal
Ladislav Novak
Jaroslav Zemanek
Original Assignee
Jan Harmaniak
Ervin Kovacik
Pavol Konecny
Vitezslav Latal
Ladislav Novak
Jaroslav Zemanek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Harmaniak, Ervin Kovacik, Pavol Konecny, Vitezslav Latal, Ladislav Novak, Jaroslav Zemanek filed Critical Jan Harmaniak
Priority to CS836478A priority Critical patent/CS235580B1/en
Publication of CS647883A1 publication Critical patent/CS647883A1/en
Publication of CS235580B1 publication Critical patent/CS235580B1/en

Links

Landscapes

  • Refinement Of Pig-Iron, Manufacture Of Cast Iron, And Steel Manufacture Other Than In Revolving Furnaces (AREA)

Abstract

Zliatiina vhodná pre očkovanie a modifikáciu šedej liatiny, připadne iných druhov liatin a surového železa, je vyrobená na báze ferosilícia a obsahuje okrem železa 40 až 80 °/o kremíka, 1 až 6 % manganu, 1 až 3 % hliníka, 0,2 až 2 % vápnika v hmotnostných podieloch.The alloy suitable for inoculating and modifying gray cast iron, or other types of cast iron and pig iron, is made on the basis of ferrosilicon and contains, in addition to iron, 40 to 80% silicon, 1 to 6% manganese, 1 to 3% aluminum, 0.2 to 2% calcium in weight fractions.

Description

Vynález sa týká očkovacej a modifikačnej zliatiny n!a báze ferosilícia.The invention relates to a vaccine and a modifying alloy n! and ferrosilicon bases.

Doposia! známe očkovacie a modifikačné zliatiny, vyrábané na báze ferosilícia obsahujú doplňujúce elementy zvyšujúce účinok očkovania a modifikácie liatiny, například vápník, kovy vzácných zemin, stroncium, zirkon, titan, připadne ich kombinácie a pod. Prostredníctvom týchto elementov, ktoré sa pri očkovaní a modifikácii vnášajú do liatiny, alebo surového železa sa zlepšujú vlastnosti očkovaných materiálov alebo odliatkov.So far the! known inoculation and modification alloys produced on the basis of ferro-silicon contain additional elements increasing the effect of inoculation and modification of cast iron, for example calcium, rare earth metals, strontium, zirconium, titanium, or combinations thereof and the like. These elements, which are introduced into the cast iron or pig iron during inoculation and modification, improve the properties of the inoculated materials or castings.

Nedostatkom doposia! vyrábaných očkovacích a modifikačných zliatín je to, že pre zvýšenie očkovacieho a modifikačného účinku využívajú ťažko dostupné prvky, alebo prvky bežne vyrábané, ale vo vzájomnej kombinácii, ktorá neposkytuje žiadúci očkujúcl a modifíkačný účinok.Lack of so far! of the vaccine and modification alloys produced is that they use hardly available or commonly manufactured elements to enhance the vaccination and modification effect, but in combination with each other that does not provide the desired vaccination and modifying effect.

Tento nedostatok odstraňuje očkovacia a modifikačná zliatina na báze ferosilícia podfa vynálezu. Podstata spočívá v tom, že zliatina pozostáva z 40 až 80 % kremíka, 1 až 6 % mangánu, 1 až 3 % hliníka, 0,2 až % vápnika, zbytok železo, v hmotnostných dieloch.This drawback is overcome by the ferro-silicate seed and modification alloy of the invention. The principle is that the alloy consists of 40 to 80% silicon, 1 to 6% manganese, 1 to 3% aluminum, 0.2 to% calcium, the remainder iron, in parts by weight.

Výhodou zliatiny podlá vynálezu je, že elementární zvyšujúcimi účinok očkovania a modifikácie sú prvky bežne vyrábané a 1'ahko dostupné, pričem ich hmotnostně zastúpenie v zliatine, ktoré je predmetom tohto vynálezu zaisťuje vysoký očkovací a modifikačný účinok v liatine, resp. v surovom železe.It is an advantage of the alloy according to the invention that the elementally enhancing effect of inoculation and modification are the elements commercially manufactured and readily available, while their weight in the alloy, which is the subject of the present invention, ensures high inoculation and modification effect in the cast iron, respectively. in pig iron.

Výrobu očkovacej a modifikačnej zliatiny podlá vynálezu možno prevádzať na elektrickej oblúkovej peci tým, že sa do vsádzky ferosilícia pridávajú substráty obsahujúce vápník, hliník, mangán alebo dávkou týchto kovov do. pánve, připadne ich vzájomnou kombináciou.The production of the inoculation and modification alloy according to the invention can be carried out in an electric arc furnace by adding substrates containing calcium, aluminum, manganese or a batch of these metals to the ferro-silicon charge. pans, if any, by combining them.

Příkladné bola vyrobená zliatina obsahujúca v hmotnostných podieloch 72 % kremíka, 3,5 % mangánu, 2,1 % hliníka, 0,7 % vápnika, zbytok železo. Hotový produkt sa odlieval do kokil a upravil na potrebnú kusovosť. Pri použití vykázala uvedená zliatina velmi dobrý očkovací účinok.By way of example, an alloy containing 72% by weight of silicon, 3.5% of manganese, 2.1% of aluminum, 0.7% of calcium, and the remainder iron was produced. The finished product was cast into chill molds and adjusted to the required lumpiness. In use, the alloy showed a very good vaccination effect.

Claims (1)

PREDMETSUBJECT Zliatina pre očkovanie a modifikáciu liatiny alebo surového železa, na bázi ferosilícia, vyznačujúci sa tým, že pozostáva v vynalezu hmotnostných podieloch z 40 až 80 % kremíka, 1 až 6 % mangánu, 1 až 3 % hliníka, 0,2 až 2 o/o vápnika, zbytok železo.Ferro-silicon-based inoculation and modification alloy for cast iron or pig iron, characterized in that it consists in the inventive proportions by weight of 40 to 80% silicon, 1 to 6% manganese, 1 to 3% aluminum, 0.2 to 2% about calcium, the rest iron.
CS836478A 1983-09-06 1983-09-06 Vaccination and modification alloy CS235580B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS836478A CS235580B1 (en) 1983-09-06 1983-09-06 Vaccination and modification alloy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS836478A CS235580B1 (en) 1983-09-06 1983-09-06 Vaccination and modification alloy

Publications (2)

Publication Number Publication Date
CS647883A1 CS647883A1 (en) 1984-05-14
CS235580B1 true CS235580B1 (en) 1985-05-15

Family

ID=5411931

Family Applications (1)

Application Number Title Priority Date Filing Date
CS836478A CS235580B1 (en) 1983-09-06 1983-09-06 Vaccination and modification alloy

Country Status (1)

Country Link
CS (1) CS235580B1 (en)

Also Published As

Publication number Publication date
CS647883A1 (en) 1984-05-14

Similar Documents

Publication Publication Date Title
GB1126013A (en) Process for production of as-cast nodular iron
GB1258824A (en)
CS235580B1 (en) Vaccination and modification alloy
GB1320271A (en) Aluminium alloys
GB1289627A (en)
GB1341144A (en) Casting composition containing aluminium a process fo preparing same and castings made from same
ATE4330T1 (en) PROCESS FOR PRODUCTION OF ALUMINUM ALLOYS.
RU93031166A (en) METHOD OF OBTAINING HIGH-STRENGTH IRON WITH SPARKET GRAPHITE
GB820583A (en) Improvements in or relating to aluminium alloys and the production of coloured surfaces thereon
US3177072A (en) Alloy containing magnesium, silicon, and calcium
SU509087A1 (en) Modifier
US2242205A (en) Manganese alloy
SU534512A1 (en) Ligature
GB513783A (en) An improved method of treating cast-iron and steel with ferro-alloys
US4209324A (en) Titanium-containing treatment agents for molten ferrous metal
SU1366536A1 (en) Inoculating mixture
SU827583A1 (en) Iron-based alloy
GB318802A (en) Improvements relating to alloys
SU401746A1 (en) COMPLEX MODIFIER FOR GRAY ANIMAL
GB1448771A (en) Nodular cast iron and a method of producing same
SU368329A1 (en) METHOD OF OBTAINING LIGATURES
GB1397600A (en) Method and briquette for nodulating cast iron
JPS6041683B2 (en) Additives for cast iron
GB672618A (en) Improvements relating to alloys for addition to cast iron
SU1153563A1 (en) METHOD OF MODIFICATION OF MAGNETIC ALLOYS